Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Receivables (2016 - 2025)

Historic Receivables for iBio (IBIO) over the last 16 years, with Q3 2025 value amounting to $65000.0.

  • iBio's Receivables changed N/A to $65000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $65000.0, marking a year-over-year change of. This contributed to the annual value of $1.0 million for FY2022, which is 9019.61% down from last year.
  • iBio's Receivables amounted to $65000.0 in Q3 2025.
  • In the past 5 years, iBio's Receivables registered a high of $10.2 million during Q2 2021, and its lowest value of $65000.0 during Q3 2025.
  • Moreover, its 4-year median value for Receivables was $5.1 million (2021), whereas its average is $4.2 million.
  • As far as peak fluctuations go, iBio's Receivables skyrocketed by 1350000.0% in 2021, and later tumbled by 9019.61% in 2022.
  • iBio's Receivables (Quarter) stood at $5.1 million in 2021, then changed by 0.0% to $5.1 million in 2022, then changed by 0.0% to $5.1 million in 2023, then tumbled by 98.73% to $65000.0 in 2025.
  • Its Receivables was $65000.0 in Q3 2025, compared to $5.1 million in Q1 2023 and $5.1 million in Q4 2022.